Dennis Podlesak
CIK 1314595 · last filed 2026-02-06
Dennis Podlesak is a corporate insider who has filed 34 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SNDX, was dated Feb 6, 2026. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.38M
4
34
-$2.58M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Director | 239,763 | $18.25 | $4.38M | -$2.58M | 16 | 2026-02-06 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 336,394 | — | — | $0 | 8 | 2014-02-14 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | — | — | — | $0 | 2 | 2014-01-03 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-06 | SNDX | Grant (A) | +48,000 | $0 | EDGAR |
| 2025-08-18 | SNDX | Mixed | — | -$460.4K | EDGAR |
| 2025-02-07 | SNDX | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-02-09 | SNDX | Grant (A) | +34,000 | $0 | EDGAR |
| 2023-02-03 | SNDX | Grant (A) | +32,000 | $0 | EDGAR |
| 2022-09-16 | SNDX | Mixed | — | -$1.40M | EDGAR |
| 2022-02-03 | SNDX | Grant (A) | +32,000 | $0 | EDGAR |
| 2021-10-06 | SNDX | Other (J) | +463 | $0 | EDGAR |
| 2021-04-22 | SNDX | Buy (P) | +13,967 | $197.1K | EDGAR |
| 2021-02-05 | SNDX | Grant (A) | +29,333 | $0 | EDGAR |